Methods: DATA were enrolled from the Alzheimers Disease Neuroimaging Initiative (ADNI) database, and we studied healthy individuals (as controls, a total of 54), patients with mild cognitive impairment (345), and patients with Alzheimers disease (96) A one-year follow-up was conducted to collect data on the dynamic changes of GST protein levels in plasma and primary information data, and to analyze the correlation between the changes in GST protein levels before and after the follow-up and cognitive function and its predictive value
Zhu C, Sawrey-Kubicek L, Bardagjy AS, Houts H, Tang X, Sacchi R, et al
Similarly, GLP-1 users were younger (mean age 58 v 67) and had a higher body mass index (36.2 v 31.3) than DPP-4 inhibitor users
CYP11A1 could regulate serum-free medium-induced cell mitophagy via changing cholesterol content
This is fundamentally different from how semaglutide and other GLP-1 drugs work
High-dose alfacalcidol improves anaemia in patients on haemodialysis
